Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 339 followers
Latest posts
Last updated about 7 hours ago
‘Not simply saving cost’: Inside Astellas CEO’s 5-year strategy to counter Xtandi’s patent cliff
about 7 hours ago
Staring down a $6 billion patent cliff for its prostate cancer drug...
Roche nabs EU approval on label expansions for companion dx platform
about 13 hours ago
Roche received approval through the EU’s In Vitro diagnostic regulation for several...
Genentech executes another round of layoffs, with 3 VPs axed
about 13 hours ago
Genentech vice presidents Vishva Dixit, Man-Wah Tan and Todd McDevitt are among...
Redefining what success looks like in PSC: The evolution of clinical trial endpoints
about 13 hours ago
As understanding of rare cholestatic liver diseases has evolved, endpoint science and...
AI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data finds
about 14 hours ago
There was a big uptick in the use of AI across all...
Novo reports data breach, tells clinical trial patients to 'remain vigilant'
about 14 hours ago
As cybersecurity threats have proliferated across industries in recent years, biopharma companies...
Predicta links with Spanish university to offer diagnostic for blood cancers
about 15 hours ago
Predicta Biosciences, a precision oncology specialist, is teaming with the Clínica Universidad...
Beyond Rigid Platforms: Adaptive Adenoviral Platform De-Risks Development to GMP
about 16 hours ago
Rigid adenoviral platforms can derail GMP progress. Learn how adaptive, adenovirus-specific strategies...
How NEC's AI and oral delivery system are redefining personalized cancer therapy
about 16 hours ago
Neoantigen-based therapies are considered one of the most promising approaches in modern...
Fierce Biotech heading to UK to host event amid London Life Sciences Week
about 17 hours ago
Fierce Biotech is returning to the U.K. in November for a day...
Cardiovascular-focused Kardigan plans to bring in cozy $320M haul from upcoming IPO
about 20 hours ago
Kardigan has sewn up its IPO plans, with the cardiovascular biotech expecting...
Caribou boosts case that off-the-shelf CAR-T matches autologous drugs ahead of phase 3
about 20 hours ago
Caribou Biosciences has linked its CAR-T cell therapy candidate to 17.1-month median...